Effectiveness and Safety of Low-Threshold Opioid-Agonist Treatment in Hard-To-Reach Populations with Opioid Dependence
Author(s) -
Fatemeh Chalabianloo,
Christian Ohldieck,
Øystein Ariansen Haaland,
Lars Thore Fadnes,
Kjell Arne Johansson
Publication year - 2021
Publication title -
european addiction research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.862
H-Index - 54
eISSN - 1421-9891
pISSN - 1022-6877
DOI - 10.1159/000520185
Subject(s) - medicine , cohort , opioid , confidence interval , opioid use disorder , opioid overdose , cohort study , drug overdose , rate ratio , emergency medicine , anesthesia , poison control , (+) naloxone , receptor
Opioid-use disorder is related to premature death worldwide. Opioid-agonist treatment (OAT) is an effective treatment for opioid dependence. OAT delivery platforms may influence treatment access and outcomes, especially for the most vulnerable groups. The aim of this study was to determine the effectiveness and safety of low-threshold OAT compared to the standard treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom